Japan has decided to retain its existing accounting rule requiring companies to amortize goodwill from mergers and acquisitions over a fixed period, typically up to 20 years, rather than adopting the international standard that relies on impairment testing instead of systematic amortization [1]. This decision means Japanese accounting standards will continue to differ significantly from those in the U.S. and Europe, where companies do not regularly write off goodwill, resulting in higher reported profits and different stock valuations compared to their Japanese counterparts [1].
The proposal to shift toward the international approach was set aside due to concerns about the potential for sudden impairment losses, which could create volatility in profits and undermine investor confidence if goodwill is judged to be impaired [1]. An industry executive familiar with the accounting discussion stated, "The risk of impairment losses is a big concern. A sudden drop in value would have a major impact on earnings" [1].
Market analysts highlight that the continued use of goodwill amortization affects how Japanese companies are valued, especially in comparison to international peers who benefit from higher reported profits by not amortizing goodwill [1]. This accounting disparity can discourage cross-border mergers and acquisitions and influences trading sentiment, as investors may be cautious about the possibility of sudden impairment charges impacting share prices [1].
While there are no major changes to technical chart indicators or price levels directly attributed to this accounting rule, the ongoing use of goodwill amortization continues to shape investor perceptions and market sentiment toward Japanese listed companies involved in M&A activity [1].
CONCLUSION
Japan's decision to maintain its goodwill amortization rule sets it apart from global accounting practices and may continue to affect the valuation and investor sentiment of Japanese companies involved in M&A. The move reflects concerns about profit volatility from impairment losses, but also perpetuates challenges in cross-border dealmaking and international comparisons.